NCT00132626View on ClinicalTrials.gov

Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

September 30, 1992

Study Completion Date

August 31, 2005

Conditions

Parkinson's DiseaseParkinsonian Syndrome

Interventions

DRUG

[123I]ß-CIT and SPECT imaging

Sponsors

Collaborators (1)

Molecular NeuroImaging

All Listed Sponsors

collaborator

Molecular NeuroImaging

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

Institute for Neurodegenerative Disorders

OTHER